Targeting public neoantigens for cancer immunotherapy (vol 2, pg 487, 2021)

被引：2
|
作者：
Pearlman, Alexander H.
Hwang, Michael S.
Konig, Maximilian F.
Hsiue, Emily Han-Chung
Douglass, Jacqueline
DiNapoli, Sarah R.
Mog, Brian J.
Bettegowda, Chetan
Pardoll, Drew M.
Gabelli, Sandra B.
Papadopoulos, Nicholas
Kinzler, Kenneth W.
Vogelstein, Bert
Zhou, Shibin
机构：
[1] The Johns Hopkins University School of Medicine,Ludwig Center, Sidney Kimmel Comprehensive Cancer Center
[2] The Johns Hopkins University School of Medicine,Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center
[3] Howard Hughes Medical Institute,Division of Rheumatology, Department of Medicine
[4] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering
[5] Johns Hopkins University,Department of Neurosurgery
[6] The Johns Hopkins University School of Medicine,Department of Oncology
[7] The Johns Hopkins University School of Medicine,Bloomberg~Kimmel Institute for Cancer Immunotherapy
[8] Sidney Kimmel Comprehensive Cancer Center,Department of Biophysics and Biophysical Chemistry
[9] The Johns Hopkins University School of Medicine,Department of Medicine
[10] The Johns Hopkins University School of Medicine,Department of Pathology
[11] The Johns Hopkins University School of Medicine,Sol Goldman Pancreatic Cancer Research Center
[12] The Johns Hopkins University School of Medicine,undefined
[13] Genentech,undefined
[14] Inc.,undefined
来源：
NATURE CANCER | 2021年 / 2卷 / 08期
关键词：
D O I：
10.1038/s43018-021-00246-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：865 / 867
页数：3
相关论文
共 50 条
  • [1] Targeting public neoantigens for cancer immunotherapy
    Pearlman, Alexander H.
    Hwang, Michael S.
    Konig, Maximilian F.
    Hsiue, Emily Han-Chung
    Douglass, Jacqueline
    DiNapoli, Sarah R.
    Mog, Brian J.
    Bettegowda, Chetan
    Pardoll, Drew M.
    Gabelli, Sandra B.
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Zhou, Shibin
    NATURE CANCER, 2021, 2 (05) : 487 - +
  • [2] Targeting public neoantigens for cancer immunotherapy
    Alexander H. Pearlman
    Michael S. Hwang
    Maximilian F. Konig
    Emily Han-Chung Hsiue
    Jacqueline Douglass
    Sarah R. DiNapoli
    Brian J. Mog
    Chetan Bettegowda
    Drew M. Pardoll
    Sandra B. Gabelli
    Nicholas Papadopoulos
    Kenneth W. Kinzler
    Bert Vogelstein
    Shibin Zhou
    Nature Cancer, 2021, 2 : 487 - 497
  • [3] Author Correction: Targeting public neoantigens for cancer immunotherapy
    Alexander H. Pearlman
    Michael S. Hwang
    Maximilian F. Konig
    Emily Han-Chung Hsiue
    Jacqueline Douglass
    Sarah R. DiNapoli
    Brian J. Mog
    Chetan Bettegowda
    Drew M. Pardoll
    Sandra B. Gabelli
    Nicholas Papadopoulos
    Kenneth W. Kinzler
    Bert Vogelstein
    Shibin Zhou
    Nature Cancer, 2021, 2 : 865 - 867
  • [4] Targeting neoantigens for cancer immunotherapy
    Lu, Yong-Chen
    Robbins, Paul F.
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) : 365 - 370
  • [5] Cancer immunotherapy targeting neoantigens
    Kakimi, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 937 - 937
  • [6] Targeting neoantigens for cancer immunotherapy
    Xuan Zhao
    Xiaoxin Pan
    Yi Wang
    Yi Zhang
    Biomarker Research, 9
  • [7] Targeting neoantigens for cancer immunotherapy
    Zhao, Xuan
    Pan, Xiaoxin
    Wang, Yi
    Zhang, Yi
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [8] Cancer immunotherapy targeting neoantigens
    Lu, Yong-Chen
    Robbins, Paul F.
    SEMINARS IN IMMUNOLOGY, 2016, 28 (01) : 22 - 27
  • [9] Development of cancer immunotherapy by targeting neoantigens
    Wang, Rongfu
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 : 37 - 37
  • [10] Public neoantigens in breast cancer immunotherapy (Review)
    Sueangoen, Natthaporn
    Thuwajit, Peti
    Yenchitsomanus, Pa-Thai
    Thuwajit, Chanitra
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 54 (01)
12345